|
Market Closed -
NYSE
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 2.370 USD | -2.07% |
|
-17.42% | -73.04% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| MTNB | Delayed | |
CBOE
| MTNB | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.77 | 4.98 | 5.366 |
| Spread/Res. | -14.44% | -52.41% | -55.83% |
| Spread/Supp. | +9.04% | +94.58% | +88.92% |
| Support | 2.174 | 1.218 | 1.254 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
